查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1663455

自行给药市场，按类型、按适应症、按国家和地区 - 2025 年至 2032 年全球行业分析、市场规模、市场份额及预测

Self-administered Drugs Market, By Type, By Indication, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 284 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年自我管​​理药物市场规模价值为 885.146 亿美元，2025 年至 2032 年期间的复合年增长率为 7.10%。

自行管理药品市场-市场动态

慢性病增多

推动自我管理药物市场发展的一个主要原因是糖尿病、高血压和自体免疫疾病等慢性疾病的增加。随着越来越多的患者需要持续用药，自行服用的药物变得越来越受欢迎。这些药品让患者可以自由、方便地按时服药，不仅减轻了医疗机构的压力，也提高了患者的生活品质。此外，随着社会文化朝着更注重健康的方向转变，人们对自己的医疗保健变得更加积极主动和了解，这提高了对自我管理选择的需求和接受度。

自行管理药物市场 - 关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年），全球市场预计年复合成长率约为 7.10%

根据类型细分，预计注射药物类别将在 2024 年占据最大市场份额

根据适应症细分，疼痛管理是 2024 年的主要细分市场

从地区来看，北美是 2024 年最大的收入来源

自我管理药物市场-細項分析：

全球自我管理药物市场根据类型、适应症和地区进行细分。

根据类型，市场分为注射药物、透皮药物和吸入药物。 2024 年，市场以注射药物类别为主。随着生物製剂和生物相似药的普及，注射型自我给药越来越受欢迎。这些药物通常需要精确地给药和剂量，自动注射器和预填充注射器的新发展使得在家中使用变得更加容易。类风湿性关节炎、多发性硬化症和不同荷尔蒙异常等疾病的治疗经常需要注射药物，患者对自我注射的便利性越来越感兴趣。随着更多患者友善设备和痛苦更少的输送技术的不断开发，注射剂市场预计将快速成长。

根据适应症，市场分为糖尿病、心血管、疼痛管理、荷尔蒙替代、骨质疏鬆症和其他。 2024 年，疼痛管理类别占据主导市场。自我管理药物市场将疼痛管理作为关键的应用领域，表明对治疗急性和慢性疼痛的患者友好且有效的方法的需求不断增长。自行使用的止痛药，例如外用药膏、口服药物和透皮贴剂，在便利性和适应性方面具有显着优势，使患者能够根据需要调整治疗过程。预计由于神经性疼痛和关节炎等疾病的发生率不断上升，自我管理疼痛管理选择的需求将会增加，这些发展将有助于药物配方和传递系统。

自行管理药物市场-地理洞察

2024 年，北美在全球自我管理药物市场占据主导地位。糖尿病、癌症和骨骼疾病发生率的上升，以及这些疾病患者对自我管理药物的强烈需求，是推动这项扩张的主要因素。此外，该地区最大经济体的政府也透过提供保险来支持采用各种自行管理的药物。美国食品药物管理局药品批准数量的增加为新市场参与者的扩张铺平了道路。例如，美国食品药物管理局于 2020 年 6 月向礼来公司颁发了额外批准，批准其新型速效胰岛素“Lyumjev”，旨在帮助患有 1 型和 2 型糖尿病的成年人改善血糖控制。赖脯胰岛素的一个创新版本被称为 Lyumjev。该公司开发了一种降低 A1C 水平并快速将胰岛素吸收到血液中的解决方案。此外，它还能调节糖尿病患者餐后升高的血糖值。这项新适应症无需处方，任何人无论有无症状都可以进行检测。

然而，在整个预测期内，预计亚太地区的复合年增长率最快。慢性病的盛行、医疗费用的不断增长以及医疗服务的日益便捷，都导致该地区对简单且价格合理的治疗方案的需求日益增长。人口老化使得人们更加关注慢性病管理，从而推动了自我管理药物的使用。此外，由于医疗基础设施投资和医疗旅游业的不断发展，零售药局也被鼓励扩大其线上药品分销。

自行管理药物市场-竞争格局：

全球自我管理药物市场的领导公司包括 Omnicare、SFK Corporation、强生公司、Cardinal Health、McKesson Corporation 等。透过实施合作伙伴关係、协作、区域扩张、併购和新药开发等多种策略来保持市场竞争力，市场参与者也为其成长做出了重大贡献。此外，为了提高患者的依从性和开发先进的药物输送方法，该领域的企业正在对研发进行大量投资。为了满足患者和医疗保健专业人员不断变化的需求，新产品和新技术的不断推出加剧了市场的竞争。例如，2021年9月，雅培实验室宣布收购医疗器材製造商Walk Vascular LLC。透过扩大雅培的周边血管产品组合併推广血管内治疗解决方案，此次收购将加强患者照护。

近期发展

2024 年 2 月：FDA 批准诺华推出 Xolair(R)（奥马珠单抗）。这种自行注射的药物可以帮助预防患有 IgE 介导的食物过敏的成人和儿童的过敏性休克和其他过敏反应。

目录

第 1 章：自行用药市场概况

  • 研究范围
  • 市场估计年限

第 2 章：执行摘要

  • 市场片段
    • 自行管理药物市场片段（按类型）
    • 自行给药药物市场片段（依适应症）
    • 各国自行管理药物市场概况
    • 自行管理药物市场（按地区）摘要
  • 竞争洞察

第 3 章：自行用药的主要市场趋势

  • 自行给药的市场驱动因素
    • 市场驱动因素的影响分析
  • 自行给药的市场限制
    • 市场限制的影响分析
  • 自行给药的市场机会
  • 自我管理药物市场未来趋势

第 4 章：自行给药产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景规划
  • 规范架构分析

第 5 章：自行用药市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • 新冠肺炎疫情后影响分析
    • 表现最佳的市场区隔
    • 边际成长领域
    • 最鬆散的部分
    • 边际损失部分

第 6 章：自行用药市场格局

  • 2024 年自行用药市占率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第 7 章：自行管理药品市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 注射药物
    • 透皮药物
    • 吸入药物

第 8 章：自行管理药品市场 - 按适应症划分

  • 概述
    • 按适应症细分市场占有率分析
    • 糖尿病
    • 心血管
    • 疼痛管理
    • 荷尔蒙替代疗法
    • 骨质疏鬆症
    • 其他的

第 9 章：自行管理药品市场 - 按地区划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美自我管理药物主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按类型）
    • 北美市场规模及预测（依适应症划分）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲自行给药药物主要製造商
    • 欧洲市场规模及预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模及预测（按适应症）
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 英国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区自主给药药物主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太市场规模及预测（按类型）
    • 亚太市场规模及预测（依适应症划分）
    • 印度
    • 中国
    • 韩国
    • 日本
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲自行管理药物的主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模及预测（依适应症划分）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲的自给性药物主要製造商
    • 中东和非洲市场规模及预测（按国家/地区）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按适应症划分）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其他地区

第 10 章：主要供应商分析- 自我管理药品产业

  • 竞争仪錶板
  • 公司简介
    • Omnicare
    • SFK Corporation
    • Johnson & Johnson
    • Cardinal Health
    • McKesson Corporation
    • Wal-Mart Stores Inc
    • Express Scripts Holding Company
    • CVS Health
    • Walgreens Boots Alliance
    • Rite Aid Corporation
    • Others

第 11 章：360 度分析师视角

第 12 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV4610

REPORT HIGHLIGHT

Self-administered Drugs Market size was valued at US$ 88,514.6 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Self-administered drugs are those that patients administer to themselves. Both implanted and non-implantable infusion pumps that come into contact with the skin's surface can be used to provide these medications. Self-administered drugs also include over-the-counter, oral, and topical medicines. Patients who lead active lives are looking for medications that will not only save them time but also allow them to stay out of hospitals completely (apart from emergencies). The market for self-administered drugs is expanding as a result of this trend. Policies for reimbursement will also accelerate market expansion. Furthermore, the self-administered drugs market is expected to expand because of factors such as the migration of patient populations to developed nations and the high expense of healthcare, which incentivizes patients to use self-administered drugs.

Self-administered Drugs Market- Market Dynamics

Increase in chronic illnesses

One major reason propelling the self-administered drugs market is the increase in chronic illnesses like diabetes, hypertension, and autoimmune disorders. Drugs that are self-administered are becoming more and more popular as more patients need ongoing medicine. By giving patients the freedom and convenience to take their medications on their schedules, these pharmaceuticals not only lessen the strain on medical institutions but also improve patients' quality of life. Furthermore, individuals are becoming more proactive and knowledgeable about their healthcare due to the cultural shift towards a more health-conscious society, which is raising the demand for and acceptance of self-administered choices.

Self-administered Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on type segmentation, the Injectable Drugs category was predicted to show maximum market share in the year 2024

Based on indication segmentation, pain management was the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Self-administered Drugs Market- Segmentation Analysis:

The Global Self-administered Drugs Market is segmented on the basis of Type, Indication, and Region.

On the basis of type, the market is segregated into Injectable Drugs, Transdermal Drugs, and Inhaled Drugs. In 2024, the market was dominated by the Injectable Drugs category. With the popularity of biologics and biosimilars, injectable self-administered drugs are becoming more and more popular. These medications frequently need to be administered and dosed precisely, which new developments in auto-injectors and pre-filled syringes have made easier to use at home. Treatments for diseases like rheumatoid arthritis, multiple sclerosis, and different hormonal abnormalities frequently call for injectables, and patients are becoming more and more interested in the ease of self-administration. As more patient-friendly devices and less painful delivery technologies continue to be developed, the injectable market is predicted to increase rapidly.

Based on indication, the market is divided into Diabetes, Cardiovascular, Pain Management, Hormone Replacement, Osteoporosis, and Others. In 2024, the pain management category held a dominant market share. The market for self-administered drugs includes pain management as a crucial application area, demonstrating the rising demand for patient-friendly and efficient ways to treat both acute and chronic pain. Self-administered analgesics, such as topical creams, oral drugs, and transdermal patches, provide substantial benefits in terms of ease and adaptability, enabling patients to modify their course of treatment as necessary. It is anticipated that the need for self-managed pain management choices will increase due to the growing prevalence of diseases, including neuropathic pain and arthritis, which developments will aid in medication formulations and delivery systems.

Self-administered Drugs Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Self-administered Drugs. The rising prevalence of diabetes, cancer, and bone ailments, as well as the strong demand for self-administered drugs among patients coping with these conditions, are the main drivers of the expansion. Additionally, the government of the biggest economies in the region supports the adoption of various self-administered drugs by offering insurance. Increased USFDA medicine approvals pave the way for new market participants to expand. For instance, the USFDA granted additional clearances to Eli Lilly and Company in June 2020 for their novel rapid-acting insulin, "Lyumjev," which is intended to help adults with type 1 and 2 diabetes improve their glycemic control. An innovative version of insulin lispro is called Lyumjev. The business developed a solution to lower A1C levels and quickly absorb insulin into the bloodstream. Additionally, it regulates elevated blood sugar levels in diabetic persons after meals. Without a prescription, this new indication makes the test available to anybody with or without symptoms.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR. The prevalence of chronic illnesses, growing healthcare expenses, and easier access to healthcare services are all contributing to the region's growing need for easy and reasonably priced treatment options. The ageing population has increased attention to chronic condition management, which has fueled the use of self-administered drugs. Additionally, retail pharmacies are being encouraged to expand their online drug distribution due to the healthcare infrastructure investments and the expanding medical tourism industry.

Self-administered Drugs Market- Competitive Landscape:

Among the leading companies in the global market for self-administered drugs are Omnicare, SFK Corporation, Johnson & Johnson, Cardinal Health, McKesson Corporation, and others. By implementing several tactics, including partnerships, collaborations, regional expansion, mergers and acquisitions, and new drug development, to remain competitive in the market, the market's participants are also making a substantial contribution to its growth. Furthermore, to increase patient adherence and develop cutting-edge drug delivery methods, businesses in this sector are making significant investments in research and development. The ongoing release of new goods and technology to meet the changing demands of patients and healthcare professionals intensifies the market's competition. For instance, in September 2021, Abbott Laboratories declared that it had acquired Walk Vascular LLC, a manufacturer of medical devices. By expanding Abbott's peripheral vascular portfolio and advancing endovascular therapeutic solutions, this acquisition will enhance patient care.

Recent Development

February 2024: the FDA has given Novartis permission to introduce Xolair(R) (omalizumab). This self-injectable drug can help prevent anaphylaxis and other allergic responses in adults and children with IgE-mediated food allergies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL SELF-ADMINISTERED DRUGS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Omnicare
  • SFK Corporation
  • Johnson & Johnson
  • Cardinal Health
  • McKesson Corporation
  • Wal-Mart Stores Inc
  • Express Scripts Holding Company
  • CVS Health
  • Walgreens Boots Alliance
  • Rite Aid Corporation
  • Others

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Injectable Drugs
  • Transdermal Drugs
  • Inhaled Drugs

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY INDICATION- MARKET ANALYSIS, 2019 - 2032

  • Diabetes
  • Cardiovascular
  • Pain Management
  • Hormone Replacement
  • Osteoporosis
  • Others

GLOBAL SELF-ADMINISTERED DRUGS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Self-administered Drugs Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Self-administered Drugs Market Snippet by Type
    • 2.1.2. Self-administered Drugs Market Snippet by Indication
    • 2.1.3. Self-administered Drugs Market Snippet by Country
    • 2.1.4. Self-administered Drugs Market Snippet by Region
  • 2.2. Competitive Insights

3. Self-administered Drugs Key Market Trends

  • 3.1. Self-administered Drugs Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Self-administered Drugs Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Self-administered Drugs Market Opportunities
  • 3.4. Self-administered Drugs Market Future Trends

4. Self-administered Drugs Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Self-administered Drugs Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Self-administered Drugs Market Landscape

  • 6.1. Self-administered Drugs Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Self-administered Drugs Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2024 & 2032 (%)
    • 7.1.2. Injectable Drugs
    • 7.1.3. Transdermal Drugs
    • 7.1.4. Inhaled Drugs

8. Self-administered Drugs Market - By Indication

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 8.1.2. Diabetes
    • 8.1.3. Cardiovascular
    • 8.1.4. Pain Management
    • 8.1.5. Hormone Replacement
    • 8.1.6. Osteoporosis
    • 8.1.7. Others

9. Self-administered Drugs Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. Self-administered Drugs Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. Self-administered Drugs Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.7. France
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.7.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.7.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.8. Italy
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.8.3. Italy Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.8.4. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.9. Spain
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.10. United Kingdom
      • 9.3.10.1. Overview
      • 9.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.10.3. United Kingdom Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.10.4. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.11. Russia
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.11.2. Russia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.11.3. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.12. Netherlands
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.12.2. Netherlands Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.12.3. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.13. Sweden
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.13.2. Sweden Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.13.3. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.14. Poland
      • 9.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.14.2. Poland Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.14.3. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.3.15. Rest of Europe
      • 9.3.15.1. Overview
      • 9.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.3.15.4. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. Self-administered Drugs Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.8. South Korea
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.8.3. South Korea Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.8.4. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.9. Japan
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.9.3. Japan Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.9.4. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. Self-administered Drugs Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. Self-administered Drugs Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2019 - 2032 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)

10. Key Vendor Analysis- Self-administered Drugs Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Omnicare
    • 10.2.2. SFK Corporation
    • 10.2.3. Johnson & Johnson
    • 10.2.4. Cardinal Health
    • 10.2.5. McKesson Corporation
    • 10.2.6. Wal-Mart Stores Inc
    • 10.2.7. Express Scripts Holding Company
    • 10.2.8. CVS Health
    • 10.2.9. Walgreens Boots Alliance
    • 10.2.10. Rite Aid Corporation
    • 10.2.11. Others

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us